Immunity and Viral Infections: Modulating Antiviral Response via CRISPR-Cas Systems
- PMID: 34372578
- PMCID: PMC8310348
- DOI: 10.3390/v13071373
Immunity and Viral Infections: Modulating Antiviral Response via CRISPR-Cas Systems
Abstract
Viral infections cause a variety of acute and chronic human diseases, sometimes resulting in small local outbreaks, or in some cases spreading across the globe and leading to global pandemics. Understanding and exploiting virus-host interactions is instrumental for identifying host factors involved in viral replication, developing effective antiviral agents, and mitigating the severity of virus-borne infectious diseases. The diversity of CRISPR systems and CRISPR-based tools enables the specific modulation of innate immune responses and has contributed impressively to the fields of virology and immunology in a very short time. In this review, we describe the most recent advances in the use of CRISPR systems for basic and translational studies of virus-host interactions.
Keywords: CHIKV; CRISPR/Cas; DNA sensors; EBOV; HBV; HCV; HDV; HIV; HSV; KSHV; SARS-CoV-2; Toll-like receptor; ZIKV; cGAS/STING; epitranscriptomics; influenza A virus; interferon effector proteins; interferon induction; interferon stimulated genes; pathogen recognition receptor; pathogen-associated molecular pattern; pooled libraries; yellow fever virus.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- World Health Organization . Global Hepatitis Report. World Health Organization; Geneva, Switzerland: 2017.
-
- GBD 2016 Mortality Collaborators Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970–2016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390:1084–1150. doi: 10.1016/S0140-6736(17)31833-0. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
